The immunomodulatory effects of hypertonic saline on sepsis patients

OBJECTIVE: To approach the immunomodulatory effects of hypertonic saline (HTS) on sepsis patients

Bibliographische Detailangaben
Veröffentlicht in:Zhongguo wei zhong bing ji jiu yi xue = Chinese critical care medicine = Zhongguo weizhongbing jijiuyixue. - 1998. - 24(2012), 8 vom: 01. Aug., Seite 465-9
1. Verfasser: Ding, Wei-wei (VerfasserIn)
Weitere Verfasser: Li, Wei-qin, Tong, Zhi-hui, Li, Ning, Li, Jie-shou
Format: Aufsatz
Sprache:Chinese
Veröffentlicht: 2012
Zugriff auf das übergeordnete Werk:Zhongguo wei zhong bing ji jiu yi xue = Chinese critical care medicine = Zhongguo weizhongbing jijiuyixue
Schlagworte:Journal Article Research Support, U.S. Gov't, Non-P.H.S. CD11b Antigen ICAM1 protein, human IL1B protein, human IL6 protein, human ITGAM protein, human Interleukin-1beta Interleukin-6 Saline Solution, Hypertonic mehr... Tumor Necrosis Factor-alpha Intercellular Adhesion Molecule-1 126547-89-5 L-Selectin 126880-86-2
LEADER 01000caa a22002652 4500
001 NLM220043515
003 DE-627
005 20250214073416.0
007 tu
008 231224s2012 xx ||||| 00| ||chi c
028 5 2 |a pubmed25n0733.xml 
035 |a (DE-627)NLM220043515 
035 |a (NLM)22871404 
040 |a DE-627  |b ger  |c DE-627  |e rakwb 
041 |a chi 
100 1 |a Ding, Wei-wei  |e verfasserin  |4 aut 
245 1 4 |a The immunomodulatory effects of hypertonic saline on sepsis patients 
264 1 |c 2012 
336 |a Text  |b txt  |2 rdacontent 
337 |a ohne Hilfsmittel zu benutzen  |b n  |2 rdamedia 
338 |a Band  |b nc  |2 rdacarrier 
500 |a Date Completed 16.12.2013 
500 |a Date Revised 16.11.2017 
500 |a published: Print 
500 |a Citation Status MEDLINE 
520 |a OBJECTIVE: To approach the immunomodulatory effects of hypertonic saline (HTS) on sepsis patients 
520 |a METHODS: Twenty-four septic patients admitted to surgical intensive care unit (SICU) received 5% HTS for fluid resuscitation were prospectively enrolled from January 2009 to September 2010. Blood samples were collected at 15 minutes before, and at 15 minutes and 6, 12, and 24 hours after HTS infusion, the ability of respiratory burst of polymorphonuclear neutrophils (PMN) and the surface expression of CD11b and L-selectin in fresh whole blood was evaluated with flow cytometer. The plasma was collected to determine the solubility intercellular adhesion molecule-1 (sICAM-1), solubility L-selectin (sL-selectin), tumor necrosis factor-α(TNF-α) and interleukins (IL-6, IL-1β) 
520 |a RESULTS: The baseline before HTS infusion was set as 100. Six hours after HTS infusion, the ability of respiratory burst of PMN was significantly increased [(160.0±19.6)%] compared with the baseline (P<0.05), and then gradually recovered to normal level. The expression of CD11b and L-selectin in the surface of PMN was reduced rapidly at 15 minutes after HTS infusion, and to nadir at 12 hours [(70.4±5.7)%, (70.6±8.1)%], and L-selectin recovered to the normal level at 24 hours. Within short-term of HTS infusion, plasma inflammatory factor TNF-α was significantly decreased, and sustained a low level until 12 hours, and then gradually increased. There was no change in IL-1β. IL-6 and sICAM-1 was gradually increased, and peaked at 24 hours and 12 hours respectively, and remained at a high level. sL-selectin increased shortly at 15 minutes after HTS infusion compared with baseline, and remained the level to 12 hours, and recovered to baseline at 24 hours 
520 |a CONCLUSIONS: Delayed administration of HTS may have an immunomodulatory effect on sepsis patients, which could inhibit the activation of PMN 
650 4 |a Journal Article 
650 4 |a Research Support, U.S. Gov't, Non-P.H.S. 
650 7 |a CD11b Antigen  |2 NLM 
650 7 |a ICAM1 protein, human  |2 NLM 
650 7 |a IL1B protein, human  |2 NLM 
650 7 |a IL6 protein, human  |2 NLM 
650 7 |a ITGAM protein, human  |2 NLM 
650 7 |a Interleukin-1beta  |2 NLM 
650 7 |a Interleukin-6  |2 NLM 
650 7 |a Saline Solution, Hypertonic  |2 NLM 
650 7 |a Tumor Necrosis Factor-alpha  |2 NLM 
650 7 |a Intercellular Adhesion Molecule-1  |2 NLM 
650 7 |a 126547-89-5  |2 NLM 
650 7 |a L-Selectin  |2 NLM 
650 7 |a 126880-86-2  |2 NLM 
700 1 |a Li, Wei-qin  |e verfasserin  |4 aut 
700 1 |a Tong, Zhi-hui  |e verfasserin  |4 aut 
700 1 |a Li, Ning  |e verfasserin  |4 aut 
700 1 |a Li, Jie-shou  |e verfasserin  |4 aut 
773 0 8 |i Enthalten in  |t Zhongguo wei zhong bing ji jiu yi xue = Chinese critical care medicine = Zhongguo weizhongbing jijiuyixue  |d 1998  |g 24(2012), 8 vom: 01. Aug., Seite 465-9  |w (DE-627)NLM098227793  |x 1003-0603  |7 nnns 
773 1 8 |g volume:24  |g year:2012  |g number:8  |g day:01  |g month:08  |g pages:465-9 
912 |a GBV_USEFLAG_A 
912 |a SYSFLAG_A 
912 |a GBV_NLM 
912 |a GBV_ILN_350 
951 |a AR 
952 |d 24  |j 2012  |e 8  |b 01  |c 08  |h 465-9